top of page
Search

How stress impacts Parkinson's disease. 4 areas explored.

1. Adrenal Glands: Stress activates the body's "fight or flight" response, which involves the release of stress hormones from the adrenal glands, namely cortisol and adrenaline (epinephrine). In individuals with Parkinson's disease, the neurodegenerative process affects the brain's ability to regulate stress responses. The basal ganglia, a region significantly impacted by Parkinson's, also plays a role in regulating stress responses. Dysregulation of this system can lead to an overactive stress response and contribute to the progression of Parkinson's symptoms.

2. Hormone Production: Stress can disrupt the delicate balance of various hormones in the body, affecting both the central nervous system and the endocrine system. Hormones like cortisol, epinephrine, and norepinephrine are released during stress, and their imbalances can influence the progression of Parkinson's disease. Additionally, chronic stress may lead to reduced production of certain hormones, which can exacerbate symptoms and contribute to the disease's progression.

3. Inflammation: Chronic inflammation is increasingly recognized as a factor in the progression of Parkinson's disease. Stress triggers an inflammatory response in the body, mediated by various immune molecules. This response can lead to the activation of microglia (immune cells in the brain) and the release of pro-inflammatory cytokines. In individuals with Parkinson's, this inflammation can accelerate the degeneration of dopamine-producing neurons, worsening motor symptoms. Moreover, chronic inflammation may contribute to the formation of Lewy bodies, abnormal protein aggregates characteristic of Parkinson's.

4. Microbiome: The gut-brain axis is a bidirectional communication system between the gastrointestinal tract and the brain. Emerging research suggests that the gut microbiome, which consists of trillions of microorganisms living in the digestive tract, may play a role in Parkinson's disease. Stress can alter the composition and diversity of the gut microbiota, potentially impacting the progression of Parkinson's. Dysbiosis (imbalanced gut microbiome) might contribute to neuroinflammation, affect the metabolism of neurotransmitters, and influence the integrity of the gut lining, which is important for preventing the migration of harmful substances into the bloodstream.

In summary, stress can have multifaceted effects on Parkinson's disease, impacting the adrenal glands, hormone production, inflammation, and the gut microbiome. Chronic stress may worsen symptoms and accelerate disease progression by disrupting the brain's stress response regulation, promoting inflammation, and altering the gut-brain axis. Understanding these complex interactions is crucial for developing holistic approaches to managing Parkinson's disease that address not only the neurological aspects but also the broader physiological and systemic influences. It's important for individuals with Parkinson's to incorporate stress management techniques, maintain a healthy lifestyle, and work closely with healthcare professionals to optimize their well-being.


 
 

Recent Posts

See All

'Living well naturally with Parkinson's until there is a cure'.

  • Facebook
  • Twitter

Useful Links

Contact Us

hello@macudopa.com

Call or text us:  +44 (0) 7931 293 934 

Monday to Friday 9am to 5pm UK time

*Disclaimer UK

All the information included on this website is for information purposes only. It is not intended to treat or diagnose any medical condition, nor is it intended as a substitute for medical advice.  If you are concerned about any symptoms please visit your GP for investigation and diagnosis. For medical diagnosis and treatment please consult your specialist or doctor.

© 2025 CogniBrain LTD. All rights reserved.

The content provided in connection with MacuDopa, including but not limited to text, product descriptions, research summaries, FAQs, and proprietary information regarding our Mucuna-based formulation, is protected under copyright law. Unauthorized use, reproduction, or distribution of any part of this content is prohibited without prior written permission from CogniBrain LTD. MacuDopa and related intellectual property are the sole property of CogniBrain LTD, and any infringement will be pursued to the fullest extent permitted by law.

bottom of page